In vivo schistosomicidal activity of (±)-licarin A-loaded poly (ε-caprolactone) nanoparticles

被引:0
|
作者
Lima, Thais C. [1 ]
Magalhaes, Lizandra G. [1 ]
Paula, Lucas A. de L. [1 ]
Cunha, Wilson R. [1 ]
Januario, Ana H. [1 ]
Pauletti, Patricia M. [1 ]
Bastos, Jairo K. [2 ]
Mnuquian, Hallana Alves [1 ]
Forim, Moacir R. [3 ]
Morais-Urano, Raquel P. [4 ]
Laurentiz, Rosangela S. [5 ]
Tondato, Wellington N. [5 ]
Molina, Eduardo F. [1 ]
Santos, Mario F. C. [6 ]
Silva, Marcio L. A. E. [1 ]
机构
[1] Univ Franca, Av Dr Armando Salles Oliveira 201, BR-14404600 Franca, SP, Brazil
[2] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Av Cafe S-N, BR-14040903 Ribeirao Preto, SP, Brazil
[3] Univ Fed Sao Carlos, Dept Quim, Rod Washington Luiz,S-N Monjolinho, BR-13565905 Sao Carlos, SP, Brazil
[4] Univ Sao Paulo, Inst Quim Sao Carlos, Av Trab Sao Carlense,400 Parque Arnold Schmidt, BR-13566590 Sao Carlos, SP, Brazil
[5] Univ Estadual Paulista, Fac Engn Ilha Solteira, Dept Fis & Quim, Rua Moncao,226 Zona Norte, BR-15385000 Sao Paulo, Brazil
[6] Univ Fed Espirito Santo, Dept Quim & Fis, Ctr Ciencias Exatas Nat & Saude, Alto Univ S-N, BR-29500000 Alegre, ES, Brazil
基金
巴西圣保罗研究基金会; 瑞典研究理事会;
关键词
Schistosoma mansoni(?)-licarin A; Nanotechnology; SCHISTOSOMA-MANSONI; VITRO; RELEASE;
D O I
10.1016/j.exppara.2022.108357
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Schistosomiasis mansoni is an infectious parasitic disease caused by worms of the genus Schistosoma, and pra-ziquantel (PZQ) is the medication available for the treatment of schistosomiasis. However, the existence of resistant strains reinforces the need to develop new schistosomicidal drugs safely and effectively. Thus, the (& PLUSMN;)-licarin A neolignan incorporated into poly-8-caprolactone (PCL) nanoparticles and not incorporated were evaluated for their in vivo schistosomicidal activity. The (& PLUSMN;)-licarin A-loaded poly(epsilon-caprolactone) nanoparticles and the pure (& PLUSMN;)-licarin A showed a reduction in the number of worm eggs present in spleens of mice infected with Schistosoma mansoni. In addition, the (& PLUSMN;)-licarin A incorporated in the concentration of 20 mg/kg and 200 mg/kg reduced the number of worms, presenting percentages of 56.3% and 41.7%, respectively.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Rapamycin- loaded poly( ε- caprolactone)- poly( ethylene glycol)- poly( ε- caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation
    Zhang, Zhaoliang
    Xu, Lu
    Chen, Hao
    Li, Xingyi
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2014, 66 (04) : 557 - 563
  • [22] Cyclosporin A-loaded poly(d,l-lactide) nanoparticles: a promising tool for treating alopecia
    Fernandes, Bruno
    Matama, Teresa
    Gomes, Andreia C.
    Cavaco-Paulo, Artur
    [J]. NANOMEDICINE, 2020, 15 (15) : 1459 - 1469
  • [23] (±)-Licarina-A loaded PICA nanoparticles: Preparation and in vitro schistosomicidal activity for controlled release
    Lima, T. C.
    Cunha, W. R.
    Magalhaes, L. G.
    Bastos, J. K.
    Pereira, A. C.
    Luz, P. P.
    Silva, M. L. A.
    [J]. PLANTA MEDICA, 2012, 78 (11) : 1079 - 1079
  • [24] Pharmacokinetic and Tissue Distribution of Orally Administered Cyclosporine A-Loaded poly(ethylene oxide)-block-Poly(ε-caprolactone) Micelles versus Sandimmune® in Rats
    Ziyad Binkhathlan
    Raisuddin Ali
    Wajhul Qamar
    Hanan Al-Lawati
    Afsaneh Lavasanifar
    [J]. Pharmaceutical Research, 2021, 38 : 51 - 65
  • [25] Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(ε-caprolactone) nanoparticles
    Misra, Ranjita
    Acharya, Sarbari
    Dilnawaz, Fahima
    Sahoo, Sanjeeb K.
    [J]. NANOMEDICINE, 2009, 4 (05) : 519 - 530
  • [26] Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: In vitro and in vivo evaluation
    Xin, Hongliang
    Chen, Liangcen
    Gu, Jijin
    Ren, Xiaoqing
    Wei, Zhang
    Luo, Jieqi
    Chen, Yanzuo
    Jiang, Xinyi
    Sha, Xianyi
    Fang, Xiaoling
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) : 238 - 247
  • [27] Paclitaxel-loaded polymeric micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) triblock copolymers: in vitro and in vivo evaluation
    Zhang, Linhua
    He, Yingna
    Ma, Guilei
    Song, Cunxian
    Sun, Hongfan
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (06) : 925 - 934
  • [28] Pharmacokinetic and Tissue Distribution of Orally Administered Cyclosporine A-Loaded poly(ethylene oxide)-block-Poly(ε-caprolactone) Micelles versus Sandimmune(R) in Rats
    Binkhathlan, Ziyad
    Ali, Raisuddin
    Qamar, Wajhul
    Al-Lawati, Hanan
    Lavasanifar, Afsaneh
    [J]. PHARMACEUTICAL RESEARCH, 2021, 38 (01) : 51 - 65
  • [29] In vitro antileishmanial activity of amphotericin B loaded in poly(ε-caprolactone) nanospheres
    Espuelas, MS
    Legrand, P
    Loiseau, PM
    Bories, C
    Barratt, G
    Irache, JM
    [J]. JOURNAL OF DRUG TARGETING, 2002, 10 (08) : 593 - 599
  • [30] Formulation and physicochemical characterization of poly(ε-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium
    Arias, Jose L.
    Lopez-Viota, Margarita
    Saez-Fernandez, Eva
    Adolfina Ruiz, M.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 75 (01) : 204 - 208